Technical Considerations in the Freezing, Low-Temperature Storage and Thawing of Stem Cells for Cellular Therapies

Overview

Journal Transfus Med Hemother

Specialty Hematology

Date 2019 Jun 28

PMID 31244583

Citations 39

Authors

Charles J Hunt

Affiliations

Soon will be listed here.

Abstract

The commercial and clinical development of cellular therapy products will invariably require cryopreservation and frozen storage of cellular starting materials, intermediates and/or final product. Optimising cryopreservation is as important as optimisation of the cell culture process in obtaining maximum yield and a consistent end-product. Suboptimal cryopreservation can lead not only to batch-to-batch variation, lowered cellular functionality and reduced cell yield, but also to the potential selection of subpopulations with genetic or epigenetic characteristics divergent from the original cell line. Regulatory requirements also impact on cryopreservation as these will require a robust and reproducible approach to the freezing, storage and thawing of the product. This requires attention to all aspects of the application of low temperatures: from the choice of freezing container and cryoprotectant, the cooling rate employed and its mode of de-livery, the correct handling of the frozen material during storage and transportation, to the eventual thawing of the product by the end-user. Each of these influences all of the others to a greater or lesser extent and none should be ignored. This paper seeks to provide practical insights and alternative solutions to the technical challenges faced during cryopreservation of cells for use in cellular therapies.

Citing Articles

Quality Assurance in Metabolomics and Metabolic Profiling.

Kirwan J, Bruning U, Mosley J Methods Mol Biol. 2025; 2891():15-51.

PMID: 39812975 DOI: 10.1007/978-1-0716-4334-1_2.

Orthobiologic Products: Preservation Options for Orthopedic Research and Clinical Applications.

Fang W, Vangsness Jr C J Clin Med. 2024; 13(21).

PMID: 39518716 PMC: 11546119. DOI: 10.3390/jcm13216577.

Challenges of Cell Counting in Cell Therapy Products.

Liu M, Chu W, Guo T, Zeng X, Shangguan Y, He F Cell Transplant. 2024; 33:9636897241293628.

PMID: 39462979 PMC: 11520012. DOI: 10.1177/09636897241293628.

Enhancing organoid culture: harnessing the potential of decellularized extracellular matrix hydrogels for mimicking microenvironments.

Li C, An N, Song Q, Hu Y, Yin W, Wang Q J Biomed Sci. 2024; 31(1):96.

PMID: 39334251 PMC: 11429032. DOI: 10.1186/s12929-024-01086-7.

Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC-derived therapies.

Dobruskin M, Toner G, Kander R Biotechnol Prog. 2024; 40(6):e3504.

PMID: 39268839 PMC: 11659802. DOI: 10.1002/btpr.3504.

References

Yang J, Diaz N, Adelsberger J, Zhou X, Stevens R, Rupert A . The effects of storage temperature on PBMC gene expression. BMC Immunol. 2016; 17:6. PMC: 4791795. DOI: 10.1186/s12865-016-0144-1. View

Kaindl J, Meiser I, Majer J, Sommer A, Krach F, Katsen-Globa A . Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual-Center Study Using Adherent Vitrification. Stem Cells Transl Med. 2018; 8(3):247-259. PMC: 6392398. DOI: 10.1002/sctm.18-0121. View

Yang B, Parsha K, Schaar K, Satani N, Xi X, Aronowski J . Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model. Stem Cells Int. 2016; 2016:5876836. PMC: 4926012. DOI: 10.1155/2016/5876836. View

Lauterboeck L, Hofmann N, Mueller T, Glasmacher B . Active control of the nucleation temperature enhances freezing survival of multipotent mesenchymal stromal cells. Cryobiology. 2015; 71(3):384-90. DOI: 10.1016/j.cryobiol.2015.10.145. View

Lecchi L, Giovanelli S, Gagliardi B, Pezzali I, Ratti I, Marconi M . An update on methods for cryopreservation and thawing of hemopoietic stem cells. Transfus Apher Sci. 2016; 54(3):324-36. DOI: 10.1016/j.transci.2016.05.009. View

Simione F, Sharp T . Best practices for storing and shipping cryopreserved cells. In Vitro Cell Dev Biol Anim. 2017; 53(10):888-895. DOI: 10.1007/s11626-017-0214-6. View

Baust J, Campbell L, Harbell J . Best practices for cryopreserving, thawing, recovering, and assessing cells. In Vitro Cell Dev Biol Anim. 2017; 53(10):855-871. DOI: 10.1007/s11626-017-0201-y. View

McCullough J, Haley R, Clay M, Hubel A, Lindgren B, Moroff G . Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer. Transfusion. 2009; 50(4):808-19. DOI: 10.1111/j.1537-2995.2009.02482.x. View

Massie I, Selden C, Hodgson H, Fuller B . Storage temperatures for cold-chain delivery in cell therapy: a study of alginate-encapsulated liver cell spheroids stored at -80°c or -170°c for up to 1 year. Tissue Eng Part C Methods. 2012; 19(3):189-95. PMC: 3557435. DOI: 10.1089/ten.TEC.2012.0307. View

10.

Fahy G, Wowk B . Principles of cryopreservation by vitrification. Methods Mol Biol. 2014; 1257:21-82. DOI: 10.1007/978-1-4939-2193-5_2. View

11.

Hunt C . Cryopreservation: Vitrification and Controlled Rate Cooling. Methods Mol Biol. 2017; 1590:41-77. DOI: 10.1007/978-1-4939-6921-0_5. View

12.

Brockbank K, Carpenter J, Dawson P . Effects of storage temperature on viable bioprosthetic heart valves. Cryobiology. 1992; 29(5):537-42. DOI: 10.1016/0011-2240(92)90058-a. View

13.

Pal R, Mamidi M, Kumar Das A, Bhonde R . Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol. 2011; 86(4):651-61. DOI: 10.1007/s00204-011-0782-2. View

14.

Wowk B . Electric and magnetic fields in cryopreservation. Cryobiology. 2012; 64(3):301-3. DOI: 10.1016/j.cryobiol.2012.02.003. View

15.

Baust J, Corwin W, Snyder K, Van Buskirk R, Baust J . Cryopreservation: Evolution of Molecular Based Strategies. Adv Exp Med Biol. 2016; 951:13-29. DOI: 10.1007/978-3-319-45457-3_2. View

16.

Windrum P, Morris T, Drake M, Niederwieser D, Ruutu T . Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant. 2005; 36(7):601-3. DOI: 10.1038/sj.bmt.1705100. View

17.

Heidemann R, Lunse S, Tran D, Zhang C . Characterization of cell-banking parameters for the cryopreservation of mammalian cell lines in 100-mL cryobags. Biotechnol Prog. 2010; 26(4):1154-63. DOI: 10.1002/btpr.427. View

18.

Mendicino M, Bailey A, Wonnacott K, Puri R, Bauer S . MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014; 14(2):141-5. DOI: 10.1016/j.stem.2014.01.013. View

19.

Martin U . Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks. Front Med (Lausanne). 2018; 4:229. PMC: 5735065. DOI: 10.3389/fmed.2017.00229. View

20.

Asghar W, El Assal R, Shafiee H, Anchan R, Demirci U . Preserving human cells for regenerative, reproductive, and transfusion medicine. Biotechnol J. 2014; 9(7):895-903. PMC: 4145864. DOI: 10.1002/biot.201300074. View